<p>(<b>A</b>) Bar graph plotting the level of CXCL8 secretion following treatment of PC3 cells with 1 µM 5-FU. Values shown are plotted relative to a time-matched control and represent the mean ± S.E.M. of three independent experiments. (<b>B</b>) As in A, except that cells were treated with 1 µM pemetrexed. Differences in CXCL8 expression between time-matched control and drug-treated samples were analyzed by a two-tailed Student's t-test; *, p<0.05. (<b>C</b>) Bar graph plotting the levels of CXCL8 secretion following treatment of LNCaP cells with 1 µM 5-FU. Values shown are plotted relative to a time-matched control and represent the mean ± S.E.M. of three independent experiments.</p
<p>A) Cell proliferation was examined by BrdU assay following 24–72 h treatment with CXCL8 in A549 (...
<p>(A) Arrays containing prostate cancer tissue from 40 patients were stained for CXCL16 and CXCR6. ...
Bar graph denotes the effect of PTX after 24 hours on cells death modes. Propidium staining (CD) inc...
<p>(A) Graphs illustrating cell count assay data, determined from the treatment of PC3 cells (left p...
The current study was undertaken to characterize the effect of anti-metabolites on inducing CXCL8 si...
Background: The current study was undertaken to characterize the effect of anti-metabolites on induc...
Background: The current study was undertaken to characterize the effect of anti-metabolites on induc...
Background: The current study was undertaken to characterize the effect of anti-metabolites on induc...
<div><h3>Background</h3><p>The current study was undertaken to characterize the effect of anti-metab...
<p>(<b>A</b>) Bar graph illustrating the effect of the CXCR2 inhibitor on the CXCL8-promoted increas...
<p>(A) Graph shows average tumor volumes amongst the treatment groups over the course of the experim...
<p>1×10∧3 bulk of tumor cells or CSLCs plated in 5 replicas into 96-well plates were challenged for ...
<p>(A) Luminescence of prostatic tumors on day 15 (day of treatment initiation), 23, and 27. (B) Pho...
This study examines the effects of novel antineoplastic agents(isochalcones) on human metastatic pro...
<p>1×10∧3 bulk of tumor cells or CSLCs plated in 5 replicas into 96-well plates were challenged for ...
<p>A) Cell proliferation was examined by BrdU assay following 24–72 h treatment with CXCL8 in A549 (...
<p>(A) Arrays containing prostate cancer tissue from 40 patients were stained for CXCL16 and CXCR6. ...
Bar graph denotes the effect of PTX after 24 hours on cells death modes. Propidium staining (CD) inc...
<p>(A) Graphs illustrating cell count assay data, determined from the treatment of PC3 cells (left p...
The current study was undertaken to characterize the effect of anti-metabolites on inducing CXCL8 si...
Background: The current study was undertaken to characterize the effect of anti-metabolites on induc...
Background: The current study was undertaken to characterize the effect of anti-metabolites on induc...
Background: The current study was undertaken to characterize the effect of anti-metabolites on induc...
<div><h3>Background</h3><p>The current study was undertaken to characterize the effect of anti-metab...
<p>(<b>A</b>) Bar graph illustrating the effect of the CXCR2 inhibitor on the CXCL8-promoted increas...
<p>(A) Graph shows average tumor volumes amongst the treatment groups over the course of the experim...
<p>1×10∧3 bulk of tumor cells or CSLCs plated in 5 replicas into 96-well plates were challenged for ...
<p>(A) Luminescence of prostatic tumors on day 15 (day of treatment initiation), 23, and 27. (B) Pho...
This study examines the effects of novel antineoplastic agents(isochalcones) on human metastatic pro...
<p>1×10∧3 bulk of tumor cells or CSLCs plated in 5 replicas into 96-well plates were challenged for ...
<p>A) Cell proliferation was examined by BrdU assay following 24–72 h treatment with CXCL8 in A549 (...
<p>(A) Arrays containing prostate cancer tissue from 40 patients were stained for CXCL16 and CXCR6. ...
Bar graph denotes the effect of PTX after 24 hours on cells death modes. Propidium staining (CD) inc...